8 Αποτελέσματα
FIELD OF THE INVENTION
The present invention broadly relates to compositions comprising hepatic therapeutic actives comprising one or more acridone compounds, one or more xanthone compounds, one or more thioxanthone compounds, one or more tocotrienol compounds, and one or more oleanolic triterpenoid
FIELD OF THE INVENTION
The present invention broadly relates to compositions comprising hepatic therapeutic actives comprising one or more acridone compounds, one or more xanthone compounds, one or more thioxanthone compounds, one or more tocotrienol compounds, and one or more oleanolic triterpenoid
FIELD OF THE INVENTION
The present invention broadly relates to compositions comprising hepatic therapeutic actives comprising one or more acridone compounds, one or more xanthone compounds, one or more thioxanthone compounds, one or more tocotrienol compounds, and one or more oleanolic triterpenoid
BACKGROUND OF THE INVENTION
The present invention relates to novel xanthone derivatives, a process of preparing the same, pharmaceutical compositions comprising the same, and their use as pharmaceuticals, hair growth promotion agents, weight reduction and anti-obesity agents, and anti-inflammatory
FIELD OF THE INVENTION
The invention relates to a class of compounds which have a structure related to naturally and synthetically occurring flavanoids and to pharmaceutical uses of the compounds.
TECHNICAL FIELD
The development of multiple drug resistance represents an increasing problem in cancer
FIELD OF THE INVENTION
The present invention relates to inhibitors of DNA-dependent protein kinase (DNA-PK), and to methods of using the inhibitors to potentiate cancer treatment.
BACKGROUND OF THE INVENTION
All cells possess mechanisms to maintain integrity of the cellular genome through detection
FIELD OF THE INVENTION
This invention relates to novel compounds isolated and purified from the herb medicine Garcinia hanburi and their medical applications, and it further relates to a method of separating epimers of the compounds.
BACKGROUND OF THE INVENTION
Gamboges, the resin from various
FIELD OF THE INVENTION
The present invention relates to novel dye-sulfenate compounds, and to phototherapeutic procedures using these compounds.
BACKGROUND OF THE INVENTION
The use of visible and near-infrared (NIR) light in clinical practice is growing rapidly. Compounds absorbing or emitting in